Klingman & Associates’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Klingman & Associates’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-25	Closed	–	–	405
2016 Q2	$0	Hold	25	–	–	﹤0.01%	398
2016 Q1	$0	Hold	25	–	–	﹤0.01%	423
2015 Q4	$0	Hold	25	–	–	﹤0.01%	445
2015 Q3	$0	Hold	25	–	–	﹤0.01%	468
2015 Q2	$0	Hold	25	–	–	﹤0.01%	418
2015 Q1	$0	Hold	25	–	–	﹤0.01%	396
2014 Q4	$0	Buy	+25	New	+$22	﹤0.01%	385

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Klingman & Associates's ECTE Position: Q3 2016 in Review

Klingman & Associates sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 25 shares.

Klingman & Associates first reported a position in ECTE in Q4 2014 and held it in 7 quarters. The position peaked at $0 in Q2 2016. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

Klingman & Associates reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
Klingman & Associates sold 25 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016.
Klingman & Associates first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2014 and held it in 7 quarters.
Klingman & Associates's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $0 in Q2 2016.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Klingman & Associates's 13F filing for Q3 2016, filed 19 Oct 2016.